Literature DB >> 10651072

Infective arthritis in adults--experience at a teaching hospital in Kuwait.

P Kaushik1, A N Malaviya, V O Rotimi.   

Abstract

Infective arthritis (InfectA) has a variable geographical pattern. A 'Medline' search did not yield any earlier series on epidemiological pattern of InfectA from Kuwait or the Gulf region. Therefore, an observational prospective study of sequential cases seen over a period of 4 years was carried out. Of a total of 2021 patients seen during this period, 36 (1.8%) were diagnosed to have InfectA. There were 6 (16.7%) cases of neisserial and 30 (83.3%) of non-neisserial InfectA. Predisposing factors were seen in 17 (47.2%), all with non-neisserial InfectA. Microbiological diagnosis was proven in 15 (41.7%) cases, and included Neisseria gonorrhoeae in 5, Brucella spp. in 4, Staphylococcus aureus in 3, and Neisseria meningitidis, Salmonella spp. and Mycobacterium tuberculosis in 1 each. In the remaining 21 (58.3%) cases the diagnosis was made on clinical grounds and confirmed on therapeutic response. The most common presentation of neisserial InfectA was acute polyarthritis while that of non-neisserial InfectA was acute monoarthritis. All patients recovered with little disability and no mortality.

Entities:  

Mesh:

Year:  1999        PMID: 10651072     DOI: 10.1007/s002960050089

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  2 in total

1.  Characteristics of patients with definite septic arthritis at Hamad General Hospital, Qatar: a hospital-based study from 2006 to 2011.

Authors:  Fahmi Yousef Khan; Mohammed Abu-Khattab; Khalid Baagar; Shehab Fareed Mohamed; Islam Elgendy; Deshmukh Anand; Hani Malallah; Doiphode Sanjay
Journal:  Clin Rheumatol       Date:  2013-02-13       Impact factor: 2.980

2.  Arthritis in adults with community-acquired bacterial meningitis: a prospective cohort study.

Authors:  Martijn Weisfelt; Diederik van de Beek; Lodewijk Spanjaard; Jan de Gans
Journal:  BMC Infect Dis       Date:  2006-03-29       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.